GlaxoSmithKline: Mepolizumab recommended for approval in Europe

NEUTRAL, Fair Value 1520p vs. 1470p (+21%)
News published on September Friday 25, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities